Citigroup
DRUG

Citigroup’s Bright Minds Biosciences DRUG Stock Holding History

Citigroup’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$43.1K Buy
1,632
+1,631
+163,100% +$43.1K ﹤0.01% 4113
2025
Q1 		$36 Hold
1
– – ﹤0.01% 4669
2024
Q4 		$36 Buy
+1
New +$36 ﹤0.01% 4857